The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Substance Withdrawal Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Substance Withdrawal Syndrome


Psychiatry related information on Substance Withdrawal Syndrome


High impact information on Substance Withdrawal Syndrome


Chemical compound and disease context of Substance Withdrawal Syndrome


Biological context of Substance Withdrawal Syndrome


Anatomical context of Substance Withdrawal Syndrome


Gene context of Substance Withdrawal Syndrome


Analytical, diagnostic and therapeutic context of Substance Withdrawal Syndrome


  1. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert. Otero, M.J., Fuertes, A., Sánchez, R., Luna, G. AIDS (1999) [Pubmed]
  2. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Jorenby, D.E., Hatsukami, D.K., Smith, S.S., Fiore, M.C., Allen, S., Jensen, J., Baker, T.B. Psychopharmacology (Berl.) (1996) [Pubmed]
  3. Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users. Burstein, Y., Giardina, P.J., Rausen, A.R., Kandall, S.R., Siljestrom, K., Peterson, C.M. J. Pediatr. (1979) [Pubmed]
  4. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Hopkins, R.L., Leinung, M.C. Endocrinol. Metab. Clin. North Am. (2005) [Pubmed]
  5. High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study. Adelroth, E., Rosenhall, L., Glennow, C. Allergy (1985) [Pubmed]
  6. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. Franks, P., Harp, J., Bell, B. JAMA (1989) [Pubmed]
  7. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Holm, K.J., Goa, K.L. Drugs (2000) [Pubmed]
  8. Caffeine reinforces flavour preference in caffeine-dependent, but not long-term withdrawn, caffeine consumers. Tinley, E.M., Yeomans, M.R., Durlach, P.J. Psychopharmacology (Berl.) (2003) [Pubmed]
  9. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal. Griffiths, R.R., Evans, S.M., Guarino, J.J., Roache, J.D., Furman, W.R., Liebson, I., Schwam, E.M. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
  10. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Schweizer, E., Rickels, K., De Martinis, N., Case, G., García-España, F. Psychological medicine. (1998) [Pubmed]
  11. Randomized clinical trial of atenolol in patients with alcohol withdrawal. Kraus, M.L., Gottlieb, L.D., Horwitz, R.I., Anscher, M. N. Engl. J. Med. (1985) [Pubmed]
  12. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Smith, S.S., Gong, Q.H., Hsu, F.C., Markowitz, R.S., ffrench-Mullen, J.M., Li, X. Nature (1998) [Pubmed]
  13. Cigarette craving, smoking withdrawal, and clonidine. Glassman, A.H., Jackson, W.K., Walsh, B.T., Roose, S.P., Rosenfeld, B. Science (1984) [Pubmed]
  14. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. Dale, L.C., Hurt, R.D., Offord, K.P., Lawson, G.M., Croghan, I.T., Schroeder, D.R. JAMA (1995) [Pubmed]
  15. Physical dependence on nicotine in gum. A placebo substitution trial. Hughes, J.R., Hatsukami, D.K., Skoog, K.P. JAMA (1986) [Pubmed]
  16. Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs. Stimmel, B., Adamsons, K. JAMA (1976) [Pubmed]
  17. Failure of buspirone to protect against lorazepam withdrawal symptoms. Jerkovich, G.S., Preskorn, S.H. JAMA (1987) [Pubmed]
  18. Hooked on hormones? An anabolic steroid addiction hypothesis. Kashkin, K.B., Kleber, H.D. JAMA (1989) [Pubmed]
  19. Withdrawal symptoms after six weeks' treatment with diazepam. Murphy, S.M., Owen, R.T., Tyrer, P.J. Lancet (1984) [Pubmed]
  20. Randomized trial of acupuncture for nicotine withdrawal symptoms. White, A.R., Resch, K.L., Ernst, E. Arch. Intern. Med. (1998) [Pubmed]
  21. Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han. Sun, H.F., Chang, Y.T., Fann, C.S., Chang, C.J., Chen, Y.H., Hsu, Y.P., Yu, W.Y., Cheng, A.T. Biol. Psychiatry (2002) [Pubmed]
  22. Effects of withdrawal from long-term nicotine gum use. West, R.J., Russell, M.A. Psychological medicine. (1985) [Pubmed]
  23. Cigarette withdrawal symptoms in adolescent smokers. McNeill, A.D., West, R.J., Jarvis, M., Jackson, P., Bryant, A. Psychopharmacology (Berl.) (1986) [Pubmed]
  24. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Cheskin, L.J., Fudala, P.J., Johnson, R.E. Drug and alcohol dependence. (1994) [Pubmed]
  25. Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities. Irazusta, J., Larrinaga, G., Agirregoitia, N., Varona, A., Casis, L. Regul. Pept. (2003) [Pubmed]
  26. Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats. Halladay, A.K., Fisher, H., Wagner, G.C. Alcohol (2000) [Pubmed]
  27. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Stahl, M.M., Lindquist, M., Pettersson, M., Edwards, I.R., Sanderson, J.H., Taylor, N.F., Fletcher, A.P., Schou, J.S. Eur. J. Clin. Pharmacol. (1997) [Pubmed]
  28. Withdrawal symptoms from transdermal fentanyl (TDF) after an allogeneic peripheral blood stem cell transplant (PBSCT). Tsutsumi, Y., Kanamori, H., Tanaka, J., Asaka, M., Imamura, M., Masauzi, N. Pain medicine (Malden, Mass.) (2006) [Pubmed]
  29. Effect of sinomenine on morphine dependence in isolated guinea pig ileum. Wang, C.Y., Mo, Z.X., Tu, H.H. Di Yi Jun Yi Da Xue Xue Bao (2003) [Pubmed]
  30. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms. Okubo, T., Harada, S., Higuchi, S., Matsushita, S. Alcohol. Clin. Exp. Res. (2003) [Pubmed]
  31. Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism. Okubo, T., Harada, S., Higuchi, S., Matsushita, S. Alcohol. Clin. Exp. Res. (2002) [Pubmed]
  32. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes. Dhir, A., Naidu, P.S., Kulkarni, S.K. Addiction biology. (2005) [Pubmed]
  33. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Eap, C.B., Buclin, T., Baumann, P. Clinical pharmacokinetics. (2002) [Pubmed]
  34. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. Kampman, K.M., Volpicelli, J.R., Alterman, A.I., Cornish, J., O'Brien, C.P. The American journal of psychiatry. (2000) [Pubmed]
  35. Oral methadone self-administration: effects of dose and alternative reinforcers. Stitzer, M.L., McCaul, M.E., Bigelow, G.E., Liebson, I.A. Clin. Pharmacol. Ther. (1983) [Pubmed]
  36. Severe deficit in brain reward function associated with fentanyl withdrawal in rats. Bruijnzeel, A.W., Lewis, B., Bajpai, L.K., Morey, T.E., Dennis, D.M., Gold, M. Biol. Psychiatry (2006) [Pubmed]
WikiGenes - Universities